AVIR · Forms 3, 4, 5
Insider trades at Atea Pharmaceuticals, Inc.
No open-market insider buys or sells at Atea Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Atea Pharmaceuticals, Inc. (AVIR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Atea Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Howard Berman | Director | Options or other derivatives | Form 4 | ||||
| Arthur S Kirsch | Director | Options or other derivatives | Form 4 | ||||
| Bruno Lucidi | Director | Option exercise | 29,600 | Form 4 | |||
| Franklin M Berger | Director | Option exercise | 29,600 | Form 4 | |||
| Barbara Gayle Duncan | Director | Option exercise | 29,600 | Form 4 | |||
| Bruce Polsky | Director | Option exercise | 29,600 | Form 4 | |||
| Polly A. Murphy | Director | Option exercise | 29,600 | Form 4 | |||
| Jerome M. Adams | Director | Option exercise | 29,600 | Form 4 | |||
| Andrea Corcoran | Officer | Option exercise | 60,000 | $1.24 | $74K | Form 4 | |
| Polly A. Murphy | Director | Buy | 6,100 | $4.17 | $25K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.